Business context and reporting period
Entity note: The supplied filing is Global Medical REIT Inc. (NYSE: GMRE), not Chiron Real Estate Inc. This summary reflects the filing’s named registrant. It is an unaudited Form 10-Q for the quarter ended September 30, 2022; comparisons are with the 2021 periods.
GMRE acquires healthcare facilities and leases them primarily to physician groups and healthcare systems. At quarter-end, its portfolio comprised 118 facilities and approximately 4.9 million leasable square feet. The company completed 14 acquisitions during the first nine months of 2022.
Financial results and position
Amounts below are in millions except per-share data. Revenue and expense figures are reported in thousands in the filing.
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Total revenue | $35.4 | $30.0 | $101.0 | $85.6 |
| Net income | $10.0 | $5.4 | $18.1 | $12.9 |
| Net income attributable to common stockholders | $8.1 | $3.7 | $13.0 | $8.0 |
| Common-stockholder earnings per share | $0.12 | $0.06 | $0.20 | $0.13 |
| Operating cash flow | Not provided for quarter | Not provided for quarter | $58.2 | $51.7 |
| FFO per share and unit | $0.23 | $0.23 | $0.70 | $0.67 |
| AFFO per share and unit | $0.25 | $0.24 | $0.74 | $0.71 |
| Common dividends per share | $0.21 | $0.205 | $0.63 | $0.615 |
- Revenue and earnings: Q3 rental revenue was $35.3 million, up from $30.0 million. Net income included a $6.8 million gain on the July sale of a medical office building; before that gain, income was $3.3 million versus $5.4 million in Q3 2021. For the first nine months, income before the sale gain was $11.4 million versus $12.9 million.
- Expenses and interest: Q3 interest expense increased to $7.0 million from $4.8 million; nine-month interest expense was $17.2 million versus $14.9 million. Management attributed the increase to higher average borrowings and interest rates. Depreciation and amortization also rose, principally due to portfolio growth.
- Cash flow: Nine-month operating cash flow was $58.2 million. Investing used $135.8 million, including property investment, while financing provided $78.4 million. Cash and restricted cash totaled $13.6 million at September 30, versus $12.8 million at year-end 2021; unrestricted cash was $3.2 million.
- Debt and liquidity: Debt, net of issuance costs, was $692.8 million, up from $571.7 million at December 31, 2021. Total liabilities were $742.2 million and total equity was $664.6 million. The company reported $243.8 million of unused Credit Facility capacity as of November 1, 2022 and said it complied with facility covenants at quarter-end. The filing does not provide a single current-ratio measure.
- Rates and hedging: The weighted-average debt rate was 3.90% at quarter-end, compared with 2.87% at year-end 2021. Swaps hedge the term loans; $144.7 million of revolver borrowings remained unhedged. Management estimated a 200-basis-point SOFR increase would raise annual interest expense by about $2.9 million, assuming debt levels were unchanged.
Material changes versus the prior comparable period
- Revenue increased 18% in Q3 and 18% for the first nine months, mainly reflecting acquired properties and additional months of rent from earlier acquisitions. Reimbursed property expenses also increased, with corresponding costs recorded in operating expenses.
- Despite revenue growth, Q3 income before the property-sale gain fell $2.1 million year over year, and the nine-month amount fell $1.5 million, as expenses rose. The sale gain lifted reported net income in 2022.
- Nine-month operating cash flow rose by $6.5 million. Investing cash use decreased versus 2021, while financing cash provided fell, principally because equity proceeds were much lower than in the prior year.
- The company issued approximately 0.6 million common shares for about $10.3 million gross proceeds during the first nine months; it made no ATM issuances in Q3. The common dividend increased to $0.21 per share in Q1 2022 and remained at that level in Q2 and Q3.
Outlook, commentary, risks and unusual items
- Outlook: The filing provides no formal earnings or FFO guidance. Management expects liquidity needs to be met through operating cash flow, debt and equity financing, property dispositions and other capital transactions.
- Interest rates and capital access: Management cited inflation, Federal Reserve tightening and higher interest rates as pressures on borrowing costs and acquisition economics. It also reported that GMRE’s share price fell 25.8% from its August 16 high to November 1, increasing its cost of equity and limiting acquisition capacity. Its interest-rate estimate is sensitive to future rates and debt balances.
- Tenant and healthcare risks: Risks include lease defaults or non-renewals, rent collection, tenant financial health, labor and operating costs, and changes in Medicare, Medicaid or commercial reimbursement. COVID-19 disruptions could affect tenants and acquisition activity.
- Subsequent event—tenant bankruptcy: Pipeline Health System filed for Chapter 11 on October 3, 2022. Pipeline is the sole tenant at GMRE’s White Rock Medical Center. GMRE said it believed collection of rent due under the lease was probable, based on its review of bankruptcy documents and other analysis; the outcome remains a risk to monitor.
- Portfolio commitments: The company reported approximately $22.0 million of capital-improvement commitments, including up to $18.2 million that could be required over the next 12 months; timing and utilization are uncertain.
- Preferred stock: The 7.50% Series A preferred shares became eligible for partial or full redemption in September 2022. No shares had been redeemed at quarter-end; the liquidation preference was $77.6 million.
- Other items: The Germantown property sale generated $17.9 million gross proceeds and a $6.8 million gain. Management reported no material litigation, environmental liability or change to the risk factors disclosed in the prior annual report.
Important facts for investors to verify
- Confirm the registrant identity: the supplied filing is for Global Medical REIT Inc., despite the request naming Chiron Real Estate Inc.
- Review the Pipeline Chapter 11 case, lease status and subsequent rent collections for White Rock Medical Center.
- Assess the impact of the unhedged revolver, SOFR changes, rising interest expense and the company’s debt maturities and covenant headroom.
- Evaluate liquidity and the ability to fund acquisitions, capital commitments, debt service and common and preferred dividends; distinguish restricted from available cash.
- Separate recurring operating performance from the property-sale gain, and consider the company’s non-GAAP FFO and AFFO definitions alongside GAAP results and cash flow.